Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Fifteen Neurotechnology Startups to Present at the 2019 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Josh Makower, general partner at VC firm New Enterprise Associates, will keynote on the first day of the conference. Makower is cofounder of the Stanford Byers Biodesign Center and also founder and executive chairman of ExploraMed, a medical device incubator that has created eight companies over the past 20 years.

Robert Knight, professor of psychology and neuroscience and director emeritus of the Helen Wills Neuroscience Institute at UC Berkeley, will deliver the keynote on the second day of the event. Knight is the recipient of the Jacob Javits Neuroscience Investigator Award from the National Institutes of Health for distinguished contributions to neurological research. He is also the chief science advisor of Neurofocus Inc., the consumer neurotech spinoff company acquired by market research firm Nielsen.

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to clinical trials, securing funding, the new competitive landscape in neuromodulation, closed-loop stimulation, and neurorehabilitation. New this year is an editorial roundtable featuring Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta, who will each offer their perspectives on issues confronting the industry.

Among the companies presenting this year are Saluda Medical, Nia Therapeutics, Neuroelectrics, Humm, Evoke Neuroscience, Neural Dynamics Technologies, Spark Biomedical, Thermaquil, Humm, Neuraura, CareWear, Rune Labs, Neural Signals, and BIOS.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Maynard Cooper and Integer are Silver Sponsors, and RBrooks Group, Senso Medical, and the Cleveland FES Center are Bronze Sponsors.

"We're excited about the lineup of speakers at this year's event," said James Cavuoto, editor and publisher at Neurotech Reports. "As in the past, attendees will have many opportunities to interact with potential partners and colleagues."

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/leadersforum.html.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Advertising and Marketing, Business, Free News Articles, Reports and Studies, Surgery and Neurotechnology

New Market Research Report on Bioelectronic Medicine Forecasts $16.6B Market

SAN FRANCISCO, Calif. -- A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the worldwide market for bioelectronic medicine and related technologies will reach $16.6 billion by 2025. "The Market for Bioelectronic Medicine: 2020-2025" takes an in-depth look at the technology, markets, competitors, research, and growth rates in key application areas in the years 2020 through 2025.

"Bioelectronic medicine represents one of the most promising areas of healthcare and medical technology," said James Cavuoto, editor and publisher of Neurotech Reports. "Our team of editors and market research forecasters has more experience and expertise in this area than any other market intelligence organization."

The research report forecasts U.S. and worldwide revenue, compound annual growth rates, and competitor market shares for bioelectronic medicine devices in several key indications, including inflammatory disorders, hypertension, gastrointestinal disorders, urological disorders, cardiac disorders, metabolic disorders, and ENT disorders. It features in-depth profiles of established and startup bioelectronic medicine firms and key research institutions developing new bioelectronic and neuromodulation therapies.

A unique feature of this report is that it breaks down U.S. and worldwide revenue between core applications that conform to a classic definition of bioelectronic medicine-neuromodulation that affects an end organ-and applications that conform to an expanded definition that includes neuromodulation for neurological disorders. Also highlighted in the report is detailed information on key private and public funding agencies and venture capital firms that are investing in this space.

Authors of the report include Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta. Puerta is the former editor of the journal Bioelectronic Medicine. A team of prominent industry experts also contributed valuable input to the study including Tony Arnold, principal of the consulting firm Precys and former CEO of SetPoint Medical, and Victor Pikov, CEO of Medipace Inc. and former research platforms director at Galvani Bioelectronics.

The report is available through the Neurotech Reports website: http://www.neurotechreports.com/pages/mbmsumm.html.

About Neurotech Reports:

Neurotech Reports is the leading source of news and analysis specific to the neurotechnology industry. The firm publishes the monthly newsletter Neurotech Business Report, and also produces two annual investment conferences: the Neurotech Leaders Forum, now in its 19th year, and the Bioelectronic Medicine Forum, now in its second year. Neurotech Reports also offers strategic consulting services to commercial firms and research organizations in neuromodulation and bioelectronic medicine. Learn more at: http://www.neurotechreports.com/.

*VIDEO: Neurotech Reports editor James Cavuoto offered an overview of the report at the 2019 Bioelectronic Medicine Forum in New York - https://youtu.be/KHo6P-dYiYE

*IMAGE link for media: Send2Press.com/300dpi/19-0509s2p-nr-chart-300dpi.jpg
*Caption: "The Market for Bioelectronic Medicine: 2020-2025" examines core applications involving neuromodulation that affects an end organ, but also forecasts the market in an expanded definition that includes more traditional forms of neuromodulation.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Electronics, Free News Articles, Surgery and Neurotechnology

Sue Siegel to Keynote 2019 Bioelectronic Medicine Forum in NY

NEW YORK, N.Y. -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announces that Sue Siegel, Chief Innovation Officer at GE and CEO of GE Ventures, will keynote the 2019 Bioelectronic Medicine Forum, which takes place in New York City on April 4, 2019. The second-annual event will be held at the Millennium Broadway Hotel & Conference Center in Times Square.

Sue has more than 35 years of corporate, entrepreneurial, and venture capital experience, all geared at turning untapped potential into real value. In this role, Sue leads GE Ventures, a multimodal innovation engine focused on accelerating promising start-ups, creating and launching new companies, licensing GE's intellectual property, developing new markets, and nurturing innovative ideas into scalable initiatives both inside and outside of GE.

Sue is currently a board member at Align Technologies (ALGN), Illumina, Inc. (ILMN), and MIT's The Engine. She has been recognized in Fortune as one of "34 Leaders Who Are Changing Health Care" and as one of "The 100 Most Influential Women in Silicon Valley" by Silicon Valley Business Journal.

Other speakers at this year's event include Imran Eba, partner at Action Potential Venture Capital, Evan Norton, divisional vice president at Abbott Ventures, Jeff Erb, senior director of business development at Medtronic, Kip Ludwig, associate professor at University of Wisconsin-Madison, Elliot Krames, past president of the International Neuromodulation Society, Marom Bikson, professor of biomedical engineering at City University of New York, Shai Gozani, CEO of NeuroMetrix Inc., and Victor Pikov, a former Galvani Bioelectronics scientist and now CEO of startup Medipace Inc.

Several promising bioelectronic medicine entrepreneurs will be presenting at the meeting. These include Daniel Powell, CEO of Spark Biomedical, Thomas Oxley, CEO of Synchron Inc., developer of the Stentrode device, Jennifer Ernst, CEO of Tivic Health, Don Deyo, CEO of FemPulse LLC, Doug Adams, CEO of Qura Inc., Nader Yaghoubi, CEO of PathMaker Neurosystems Inc., and Samuel Hamner, director of technology and product marketing at Cala Health. Also presenting will be Gaurev Sharma from Battelle and Jake Zabara from the Jacob Zabara Family Foundation. Dr. Zabara was the original developer of vagus nerve stimulation for epilepsy and a cofounder of Cyberonics Inc. (now LivaNova).

Key topics will include promising indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This second-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry."

For more information on the 2019 Bioelectronic Medicine Forum, contact Neurotech Reports at (415) 546 1259 or visit this link: http://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Neuroprosthetics Pioneer to Keynote at the 2018 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. -- Neurotech Reports today announced that the keynote speaker at the 18th annual Neurotech Leaders Forum will be Hunter Peckham, a pioneer in the field of neuroprosthetics, technology that restores movement for people living with paralysis.

Peckham is a Distinguished University Professor and Donnell Institute Professor of Biomedical Engineering at Case Western Reserve University. He is also associate director of technology transfer at the Cleveland FES Center and the founder of the Institute for Functional Restoration. The event will take place October 15-16 in San Francisco, Calif.

Frank Fischer, CEO of NeuroPace Inc., has also been added to the agenda as a keynote speaker. Other additions include Eddie Chang, co-director of the Center for Neural Engineering at UC Berkeley and UC San Francisco, Philip Starr, professor of neurosurgery at UCSF, Michael Ackermann, CEO of Presidio Medical, Bashar Badran from the U.S. Army Research Laboratories, Cristin Welle, a former FDA employee and now assistant professor at University of Colorado, Nick Langhals, Neural Engineering Program Manager at the National Institutes of Health, and John Donoghue, director of the Wyss Center for Neuro and Bioengineering.

Executives from several early-stage and emerging neurotech startups will also make presentations during the event. These include Manfred Franke, founder and CEO of Neuronoff Inc., Bill Edelman, chairman of Highland Instruments, Erik Nilsen, CEO of Bio-Signal Technologies, LLC, and Howard Leonhardt, CEO of CerebraCell.

The conference returns to the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif. Platinum Sponsor at this year's conference will be Cirtec Medical. Micro Systems Technologies is the Gold Sponsor. Other sponsors include IMEC, Cactus Semiconductor, Hereaus, Senso Medical, RBrooks Group, Maynard Cooper, Cleveland FES Center, along with partners the International Neuromodulation Society and Neuromodec.

"We're pleased to have such a distinguished lineup of speakers at the 2018 Neurotech Leaders Forum," said James Cavuoto, editor and publisher of Neurotech Reports. Neurotech Reports, founded in 2001, is the leading and longest-established publishing and market-research firm covering the neurotechnology industry.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/leadersforum.html.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Funding and Investment, Surgery and Neurotechnology

Neurotech Reports Announces 2018 Investment and Management Conference for Bioelectronic Medicine

NEW YORK, N.Y. -- Neurotech Reports, the publisher of Neurotech Business Report newsletter, today announced the launch of the Bioelectronic Medicine Forum, the first investment and management conference for the bioelectronic medicine industry. The inaugural event will take place on March 22, 2018 at the Millennium Broadway Times Square in New York, N.Y.

Featured speakers include Gene Civillico, Ph.D., the Program Manager for the National Institute of Health's SPARC program. Also presenting is Eric Van Gieson, Ph.D., Program Manager at DARPA's Biological Technologies Office, which oversees the ElectRx program. These two U.S. government programs have funded much of the early research into bioelectronic medicine.

Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.

Several early-stage and emerging bioelectronic medicine firms will be presenting at the conference. These include NeuSpera Medical, which is developing a unique mid-field power technology that uses the body as a waveguide to power bioelectronic devices. Also presenting is Axion Biosystems, a manufacturer of multi-well microelectronic electrode arrays, and Neuroelectrics, a Spanish firm that manufactures noninvasive stimulation and recording devices.

The conference is co-sponsored by the Feinstein Institute for Medical Research. Imran Eba of Action Potential Venture Capital, GSK's venture arm in bioelectronic medicine, will serve as a moderator. The event takes place in the same venue and one day prior to the Future Leaders Conference, which is produced and organized by BioCentury, a global leader in business intelligence for the biopharma industry. BioCentury is pleased to serve as a marketing partner of the Bioelectronic Medicine Forum.

"Bioelectronic medicine represents one of the fastest growing segments of the life sciences industry. Participants at the 2018 Bioelectronic Medicine Forum will have an opportunity to help shape the future of this exciting field," said James Cavuoto, editor and Publisher of Neurotech Business Report.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/bioelectronic-medicine-forum.html .

*PHOTO: Send2Press.com/300dpi/18-0130s2p-Gene-Civillico-300dpi.jpg

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Key Startups and Industry Figures to Present at 2016 Neurotech Leaders Forum

SAN FRANCISCO, Calif. -- Several promising neurotechnology firms and key industry figures will present at the 2016 Neurotech Leaders Forum. The 16th annual event will take place October 24-25 in San Francisco, presented by Neurotech Reports. Keynote speaker at this year's event on October 24 will be Doug Weber, who serves as program manager for DARPA's Biological Technologies Office. Prior to joining DARPA, Weber was an associate professor of bioengineering at the University of Pittsburgh. He received his Ph.D. in bioengineering at Arizona State University.

On October 25, Adam Roth, Director of Business Development at Galvani Bioelectronics, will speak on the topic of bioelectronic medicine. Galvani was formed earlier this year as a joint venture between Google's Verily Life Sciences Unit and pharmaceutical giant GSK.

Other presenters at this year's conference are Jason Richey, president of LivaNova's neuromodulation unit, Jeff Kramer, vice president of research at St. Jude Medical Neuromodulation, David Hankin, CEO of the Alfred Mann Foundation, Frank McEachern, CEO of MicroTransponder, Inc., Aaron Kaluszka, research engineer at Lumos Labs, and Gaurav Sharma, principal research scientist at Battelle.

Neurotech entrepreneurs and startups presenting at the conference include Milton Morris, CEO of NeuSpera Medical, Roy Katz, vice-president at BlueWind Medical, Brian Blischak, president of Nexeon MedSystems, Howard Leonhardt, CEO of CerebraCell, and Chris Czura, CSO of Sanguistat.

The conference moves to a new location this year, the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif.

Platinum Sponsor at this year's conference will be Micro Systems Technologies. Cirtec Medical is the Gold Sponsor. Stellar Technologies is the Silver Sponsor.

For more information on the Neurotech Leaders Forum, contact Neurotech Reports at 415-546-1259.

The preliminary agenda is online at: http://www.neurotechreports.com/pages/nlfagenda.html.

Overview of the 2016 Neurotech Leaders Forum: http://neurotechreports.com/pages/leadersforum.html.

*PHOTO for Media: Send2Press.com/mediaboom/16-1010s2p-ntleaders-300dpi.jpg

*Photo Caption: The Neurotech Leaders Forum returns to San Francisco October 24-25.

This news story was published by the Neotrope® News Network - all rights reserved.